The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain
Authors
Keywords
Parkinson’s disease, Rotenone, Retina, Rosiglitazone, DARC
Journal
Acta Neuropathologica Communications
Volume 4, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-17
DOI
10.1186/s40478-016-0346-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Argon mediates protection by interleukin-8 suppression via a TLR2/TLR4/STAT3/NF-κB pathway in a model of apoptosis in neuroblastoma cells in vitro and following ischemia-reperfusion injury in rat retina in vivo
- (2016) Felix Ulbrich et al. JOURNAL OF NEUROCHEMISTRY
- A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson's disease
- (2016) Shahnaz Miri et al. PARKINSONISM & RELATED DISORDERS
- Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson’s disease (PD)
- (2015) Barbara Nowacka et al. DOCUMENTA OPHTHALMOLOGICA
- Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
- (2015) LANCET NEUROLOGY
- Optical coherence tomography as a tool to evaluate retinal changes in Parkinson's disease
- (2015) Pooja Mailankody et al. PARKINSONISM & RELATED DISORDERS
- Glitazone Treatment and Incidence of Parkinson’s Disease among People with Diabetes: A Retrospective Cohort Study
- (2015) Ruth Brauer et al. PLOS MEDICINE
- A semi-automated technique for labeling and counting of apoptosing retinal cells
- (2014) Mukhtar Bizrah et al. BMC BIOINFORMATICS
- Cell therapy using retinal progenitor cells shows therapeutic effect in a chemically-induced rotenone mouse model of Leber hereditary optic neuropathy
- (2014) Fiona C Mansergh et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease
- (2014) Anna R Carta et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Liposomes: Versatile and Biocompatible Nanovesicles for Efficient Biomolecules Delivery
- (2014) Sudipta Mallick et al. JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
- Neuroprotection Against Degeneration of SK-N-MC Cells Using Neuron Growth Factor-Encapsulated Liposomes with Surface Cereport and Transferrin
- (2014) Yung-Chih Kuo et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
- (2014) Juan Carlos Corona et al. NEUROCHEMICAL RESEARCH
- Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease
- (2014) M.M. Migliore et al. NEUROSCIENCE
- Retinal Nerve Fiber Layer Thickness Changes in Parkinson Disease: A Meta-Analysis
- (2014) Ji-guo Yu et al. PLoS One
- Topical Delivery of Avastin to the Posterior Segment of the Eye In Vivo Using Annexin A5-associated Liposomes
- (2014) Benjamin M. Davis et al. Small
- PPAR-γ: Therapeutic Prospects in Parkinson's Disease
- (2013) Anna R. Carta CURRENT DRUG TARGETS
- Unexpected low-dose toxicity of the universal solvent DMSO
- (2013) Joana Galvao et al. FASEB JOURNAL
- Correlation of Inner Retinal Thickness Evaluated by Spectral-Domain Optical Coherence Tomography and Contrast Sensitivity in Parkinson disease
- (2013) Christopher R. Adam et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Venturing into the no-man's land of the retina in Parkinson's disease
- (2013) Ivan Bodis-Wollner et al. MOVEMENT DISORDERS
- Development of a prediction formula of Parkinson disease severity by optical coherence tomography
- (2013) Beatriz Jiménez et al. MOVEMENT DISORDERS
- N2 Neutrophils, Novel Players in Brain Inflammation After Stroke
- (2013) María Isabel Cuartero et al. STROKE
- A phenotypic model recapitulating the neuropathology of Parkinson's disease
- (2013) Craig F. Ferris et al. Brain and Behavior
- The genetics and neuropathology of Parkinson’s disease
- (2012) Henry Houlden et al. ACTA NEUROPATHOLOGICA
- PTEN deletion enhances survival, neurite outgrowth and function of dopamine neuron grafts to MitoPark mice
- (2012) Y. Zhang et al. BRAIN
- Retinal Nerve Fiber Layer Thickness Variability in Leber Hereditary Optic Neuropathy Carriers
- (2012) Piero Barboni et al. EUROPEAN JOURNAL OF OPHTHALMOLOGY
- Pharmacological manipulation of peroxisome proliferator-activated receptor γ (PPARγ) reveals a role for anti-oxidant protection in a model of Parkinson's disease
- (2012) Heather L. Martin et al. EXPERIMENTAL NEUROLOGY
- Rosiglitazone Protects Dopaminergic Neurons Against Lipopolysaccharide-Induced Neurotoxicity Through Inhibition of Microglia Activation
- (2012) Xiuquan He et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Delivering Minocycline into Brain Endothelial Cells with Liposome-Based Technology
- (2012) Changhong Xing et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Fiji: an open-source platform for biological-image analysis
- (2012) Johannes Schindelin et al. NATURE METHODS
- The retina as a window to the brain—from eye research to CNS disorders
- (2012) Anat London et al. Nature Reviews Neurology
- Rotenone-Induced Death of RGC-5 Cells is Caspase Independent, Involves the JNK and p38 Pathways and is Attenuated by Specific Green Tea Flavonoids
- (2012) T. A. Kamalden et al. NEUROCHEMICAL RESEARCH
- Modulating Microglia Activity with PPAR-γ Agonists: A Promising Therapy for Parkinson’s Disease?
- (2012) Anna R. Carta et al. NEUROTOXICITY RESEARCH
- Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats
- (2012) Eun Young Lee et al. TOXICOLOGY LETTERS
- LHON: Mitochondrial Mutations and More
- (2011) E. Kirches CURRENT GENOMICS
- Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina
- (2011) Julián Esteve-Rudd et al. NEUROBIOLOGY OF DISEASE
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Neurotoxin-based models of Parkinson's disease
- (2011) J. Bové et al. NEUROSCIENCE
- Epidemiology, diagnosis and differential diagnosis in Parkinson's disease tremor
- (2011) Christian R. Baumann PARKINSONISM & RELATED DISORDERS
- The molecular basis of retinal ganglion cell death in glaucoma
- (2011) Mohammadali Almasieh et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Protective Effects of a Phosphatidylcholine-Enriched Diet in Lipopolysaccharide-Induced Experimental Neuroinflammation in the Rat
- (2011) Tünde Tőkés et al. SHOCK
- PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice
- (2011) Katsutaka Oishi et al. THROMBOSIS RESEARCH
- Molecular Insights into Human Monoamine Oxidase B Inhibition by the Glitazone Antidiabetes Drugs
- (2011) Claudia Binda et al. ACS Medicinal Chemistry Letters
- PPARγagonist rosiglitazone is neuroprotective after traumatic spinal cord injury via anti-inflammatory in adult rats
- (2010) Qin Zhang et al. NEUROLOGICAL RESEARCH
- Natural History of Leber's Hereditary Optic Neuropathy: Longitudinal Analysis of the Retinal Nerve Fiber Layer by Optical Coherence Tomography
- (2010) Piero Barboni et al. OPHTHALMOLOGY
- Inner Retinal Layer Thinning in Parkinson Disease
- (2009) Mohammedyusuf E. Hajee ARCHIVES OF OPHTHALMOLOGY
- The retina in Parkinson's disease
- (2009) N. K. Archibald et al. BRAIN
- PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson’s disease
- (2009) Nicoletta Schintu et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Acute action of rotenone on nigral dopaminergic neurons - involvement of reactive oxygen species and disruption of Ca2+homeostasis
- (2009) Peter S. Freestone et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- How can we recognize “disease modification” effects?
- (2009) E. R. Siemers Journal of Nutrition Health & Aging
- Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
- (2009) Malú G. Tansey et al. NEUROBIOLOGY OF DISEASE
- Protein stability and aggregation in Parkinson's disease
- (2008) Philip A. Robinson BIOCHEMICAL JOURNAL
- GSK3β and endoplasmic reticulum stress mediate rotenone-induced death of SK-N-MC neuroblastoma cells
- (2008) Yuan-Yuan Chen et al. BIOCHEMICAL PHARMACOLOGY
- Pesticide exposure and risk of Parkinson's disease: A family-based case-control study
- (2008) Dana B Hancock et al. BMC Neurology
- PPAR: a therapeutic target in Parkinsons disease
- (2008) Rajnish K. Chaturvedi et al. JOURNAL OF NEUROCHEMISTRY
- Pesticide/Environmental Exposures and Parkinson's Disease in East Texas
- (2008) Amanpreet S. Dhillon et al. Journal of Agromedicine
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started